HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical course of four patients receiving the experimental antiviral agent fialuridine for the treatment of chronic hepatitis B infection.

AuthorsW Stevenson, M Gaffey, M Ishitani, C McCullough, R Dickson, S Caldwell, P Lobo, T Pruett
JournalTransplantation proceedings (Transplant Proc) Vol. 27 Issue 1 Pg. 1219-21 (Feb 1995) ISSN: 0041-1345 [Print] United States
PMID7878856 (Publication Type: Journal Article)
Chemical References
  • Antiviral Agents
  • Lactates
  • Arabinofuranosyluracil
  • fialuridine
Topics
  • Antiviral Agents (therapeutic use, toxicity)
  • Arabinofuranosyluracil (analogs & derivatives, therapeutic use, toxicity)
  • Clinical Trials, Phase I as Topic
  • Clinical Trials, Phase II as Topic
  • Hepatitis B (blood, drug therapy)
  • Humans
  • Lactates (blood)
  • Liver Transplantation
  • Randomized Controlled Trials as Topic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: